2021
➣ Nucleotron MIT partners with Siemens Medical to collaborate in the development of new clinical and pre-clinical imaging and post-processing tools in Molecular Imaging.
2020
➣ Nucleotron MIT partners with Ionetix corporation to dramatically expand the utilization of cardiac PET with the implementation of seven additional Cardiac PET/Centers in Florida, utilizing the innovative ION 12SC system for on-demand Nh3 Ammonia production, with a 5 year plan to implement a total of 150 production sites in the USA
2019
➣ Nucleotron MIT partners with GE in the Phase II clinical Trial for Cardiac PET myocardial perfusion imaging using the novel tracer, F18-Flurpiridaz. ➣ Nucleotron MIT partners with a number of global Radio-pharmaceutical and research companies in clinical validation of novel amyloid and Tau tracers for Alzheimer diagnosis. ➣ Nucleotron MIT partners with Ionetix Corporation …
2012
➣ Nucleotron MIT partners with DraxImage-Jubilant to help optimize, register and introduce the Rubyfill Rb82 Generator in Latin America.
2011
➣ Nucleotron MIT designs, builds and assists in operation of the first BG-75 installation in Latin America
2010
➣ Nucleotron MIT partners with ABT Molecular Imaging to introduce the BG-75 Biomarker Generator System, and to complete regulatory registration for the equipment, in Latin America
2006
➣ Nucleotron MIT partners with Bracco Diagnostic to Introduce Cardiac PET using the new Cardiogen-Rb 82 Generator to the South Florida Market. ➣ Nucleotron MIT partners with CIRA to design and operate the first Cardiac PET Facility in South Florida utilizing the Cardiogen Generator